| await liver transplanta… | 0.42 |
| increase the risk | 0.34 |
| decrease function of th… | 0.32 |
| receive daklinza | 0.25 |
| prevent bile | 0.24 |
| slow normal flow of blo… | 0.20 |
| occur in response | 0.16 |
| jaundice | 0.28 |
| immune system dysfuncti… | 0.26 |
| weight loss | 0.16 |
| anemia | 0.16 |
| general weakness | 0.16 |
| fatigue | 0.16 |
| resistance | 0.16 |
| irreversible | 0.53 |
| fatal | 0.50 |
| advanced | 0.35 |
| reversible | 0.33 |
| rare | 0.25 |
| life-threatening | 0.16 |
| mild | 0.16 |
| liver failure | 0.58 |
| liver cancer | 0.44 |
| infection | 0.30 |
| kidney dysfunction | 0.26 |
| failure | 0.24 |
| impotence | 0.16 |
| child | 0.16 |
| coma | 0.16 |
| caused by alcohol abuse | 0.67 |
| caused by hepatitis c | 0.65 |
| caused by fatty liver d… | 0.56 |
| diagnosed | 0.47 |
| characterized by liver … | 0.32 |
| associated with portal … | 0.32 |
| cured | 0.25 |
| treated with antiviral … | 0.25 |
| associated with differe… | 0.25 |
| established | 0.24 |
| More » |